Article
Brochure
Executive Resource
Insight Hub
Ext. Publication
Video
Home /
Insights & Resources
Insights & Resources
Start exploring insights from across the industries we serve, featuring the latest industry trends, compliance alerts, tax and accounting news and much more.
- Alternative Investments
- Banking
- Blockchain & Digital Assets
- Construction
- Consumer Products
- Energy Transition
- Financial Services
- Food & Beverage
- General Business
- Government
- Health Care
- Higher Education
- Hospitality & Entertainment
- Industrial Products
- Insurance
- Life Sciences
- Not-for-Profit
- Oil & Gas
- Oilfield Services
- Real Estate
- Renewable Fuels
- Technology
- Transportation & Logistics
- Accounting Advisory
- Artificial Intelligence
- Asset Management Consulting
- Asset Tracing
- Cybersecurity
- Data Privacy
- Digital Transformation
- Energy Compliance
- Executive & Leadership Coaching
- Family Law
- Forensics & Litigation
- Government Consulting
- Health Care Valuation
- IT Advisory
- Risk Advisory
- Sustainability Consulting
- Transaction Advisory
- Trust & Estate
- Valuation
PodcastRetail real estate leaders discuss consumer demand, ecommerce, experiential retail and the factors shaping commercial retail development.
ASC growth continues across the U.S., but acquisition targets remain limited as more centers form through joint ventures and institutional partnerships.
Success StoryLearn how Weaver's health care disputes and investigations team quantified $81.5 million in alleged damages related to breach of fiduciary duty claims and diverted corporate opportunities.
Growth in outpatient joint procedures boomed, then slowed. Explore what’s driving the shift and valuation implications for ambulatory surgery centers.
Noncompete litigation and lost profits claims may depend on unsupported assumptions. See how Weaver clarified financial, regulatory and market realities.
A shift in Affordable Care Act (ACA) exchange volume could reshape payer mix and earnings. Explore the health care valuation implications.
The SBIR and STTR reauthorization brings larger awards, stricter eligibility and more competition for life sciences companies seeking federal funding.
Published by Medical Journal–Houston, Jerod Holloway examines how enterprise risk management is evolving across health care organization.
Shifting imaging volumes and competitive pressure challenged a hospital. Learn how our valuation analysis helped the hospital plan for a joint venture.
Tariff refunds, economic damages and importers: Supreme Court and trade rulings raise claims and recovery questions for businesses.
Four interested buyers. Operational and financial hurdles. A new ambulatory surgery center at a crossroads. Learn how Weaver guided valuation strategy.
A Supreme Court ruling has opened the door to tariff refunds. Here’s what recent updates mean for importers and potential claims.
